An evaluation of dyslipidemia in type 2 diabetes patients: North Indian teaching hospital based study
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 1, Pages 1020-1023
AbstractBackground:Dyslipidemia was defined as a combination of high serum triglyceride ≥ 1.7
mmol/L, high serum LDL cholesterol ≥ 2.6 mmol/L and low serum HDL cholesterol <
1mmol/L for men and < 1.30 mmol/L for women. Non-HDL cholesterol ≥ 3.37mmol/Land
atherogenic index ≥ 0.11, were also considered abnormalType II diabetes mellitus (T2DM),
characterized by chronic hyperglycemia, and impaired insulin secretion and insulin
resistance. The objective of the present study was to study the lipid profile among type 2
diabetes mellitus patients.
Materials & Methods: The present study was conducted in the department of general
medicine. It comprised of 62 T2DM patients of both genders. Fasting blood sugar and lipid
profile such as serum cholesterol, serum triglycerides, HDL, LDL and VLDL was assessed.
Results and Observations:There were 31 males and females each. The mean serum
cholesterol level was 228.76 mg/dl, serum TG level was 202.6 mg/dl, HDL level was 39.8
mg/dl, LDL was 142.64 mg/dl and VLDL level was 43.5 mg/dl.
Conclusion: The diabetes has a significant role in alteration of lipoprotein levels. There is
significant alteration in lipid profile levels.
- Article View: 117
- PDF Download: 123